(S,R,S)-AHPC-PEG2-NH2

CAT:
804-HY-103603A-01
Size:
25 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(S,R,S)-AHPC-PEG2-NH2 - image 1

(S,R,S)-AHPC-PEG2-NH2

  • CAS Number:

    2010159-60-9
  • UNSPSC Description:

    (S,R,S)-AHPC-PEG2-NH2 (VH032-PEG2-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker used in the synthesis of PROTACs[1].
  • Target Antigen:

    E3 Ligase Ligand-Linker Conjugates
  • Type:

    Reference compound
  • Related Pathways:

    PROTAC
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/E3_ligase_Ligand-Linker_Conjugates_6_Free_Base.html
  • Purity:

    95.41
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C([C@H]1N(C([C@@H](NC(COCCOCCN)=O)C(C)(C)C)=O)C[C@H](O)C1)NCC2=CC=C(C3=C(C)N=CS3)C=C2
  • Molecular Weight:

    575.72
  • References & Citations:

    [1]Chan KH, et al. Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds. J Med Chem. 2018 Jan 25;61(2):504-513.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    No Development Reported